GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today has announced that the Eversense® Continuous Glucose Monitoring (CGM) System has been awarded one of Popular Science’s 2018 “Best of What’s New” Awards in the Health category.
Each year, Popular Science magazine reviews thousands of new products and innovations in order to choose the top 100 winners across 10 categories. In order to win in a category, a product or technology must represent a significant step forward in its category.
“We are pleased and honored to be chosen by Popular Science as a ‘Best of What’s New’ winner for 2018,” said Tim Goodnow, President and CEO of Senseonics. “Our goal is to create innovative technology to help people with diabetes have an easier time managing their disease. This recognition just reinforces how consumer-driven medical devices can transform patients’ management of a chronic disease. At Senseonics, we’re proud that we’re changing the paradigm for diabetes care.”
The Eversense CGM System consists of a fluorescence-based sensor, a smart transmitter worn over the sensor to facilitate data communication, and a mobile app for displaying glucose values, trends and alerts. In addition to featuring the first long-term and first implantable CGM sensor, the system is also first to feature a smart transmitter that provides wearers with discreet on-body vibratory alerts for high and low glucose and that can be removed, recharged and re-adhered without discarding the sensor. The sensor can now be inserted subcutaneously in the upper arm by a health care provider via a brief in-office procedure.
“The ‘Best of What's New’ Awards allow us the chance to examine and honor the best innovations of the year,” says Popular Science Editor-in-Chief Joe Brown. “This collection shapes our future, helps us be more efficient, keeps us healthy and safe, and lets us have some fun along the way. From simple household items to massive space-exploration tools, we’re proud to bring you the Best of What's New 2018.”
Patients who are interested in getting started on Eversense can sign up at www.eversensediabetes.com/get-started-today. Physicians, nurse practitioners or physician assistants interested in offering the Eversense CGM System for their patients can contact 844-SENSE4U (844-736-7348).
The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. It is intended to complement, not replace, fingerstick blood glucose monitoring. The sensor insertion and removal is performed by a health care provider. The Eversense CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see https://eversensediabetes.com/safety-info/.
Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM systems, Eversense® and Eversense® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
About Best Of What’s New
Since 1988, the editors of Popular Science have reviewed thousands of products in search of the top 100 tech innovations of each year—breakthrough products and technologies that represent a significant advancement in their categories. Best of What's New awards are presented to 100 new products and technologies in 10 categories: Aerospace, Automotive, Engineering, Entertainment, Gadgets, Health, Home, Recreation, Security, Software.
About Popular Science
As one of America’s oldest and most trusted magazines, Popular Science has spent a century and a half bringing readers the most amazing innovations and discoveries. From thought leaders to skeptics, from digital natives to print devotees, Popular Science’s audience is as diverse as the stories in and on our pages. And we all have one thing in common: a boundless sense of wonder. Established in 1872, Popular Science is published by Bonnier Corp. Bonnier Corp. is one of the largest consumer publishing groups in the United States, and is the leading media company serving passionate, highly engaged audiences with more than 30 special interest magazines and related multimedia projects and events.